arrow
I

Inge M. van Oort

radboud university medical centre
H指数:52
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

From Genomic Testing to Olaparib Treatment: Real-World Utilization and Outcomes in BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer

从基因组检测到奥拉帕利治疗:BRCA突变的转移性去势抵抗性前列腺癌的真实世界应用与结局

2026-06-010
OA
[177Lu]-PSMA-617-PSMA-617 in oligometastatic hormone sensitive prostate cancer (BULLSEYE): an open-label, randomised, phase 2 study

[177Lu]-PSMA-617-PSMA-617 在寡转移性激素敏感性前列腺癌中的研究(BULLSEYE):一项开放标签、随机、II期研究

2026-03-300
PRE
Response to ‘Letters to the Editor’ comments on the paper ‘Impact of positive surgical margins on biochemical recurrence and metastases after radical prostatectomy’

对论文“Impact of positive surgical margins on biochemical recurrence and metastases after radical prostatectomy”的“致编辑的信”评论的回应

2026-03-180
PRE
Molecular reflex testing in patients with early metastatic castration-resistant prostate cancer within the PROMPT-study

在PROMPT研究中,早期转移性去势抵抗性前列腺癌患者的分子反射测试

2025-10-310
OA
Talazoparib Monotherapy in Metastatic Castration-resistant Prostate Cancer with DNA Damage Response Alterations—Genomic Features Associated with Response to Therapy

Talazoparib单药治疗具有DNA损伤应答改变的转移性去势抵抗性前列腺癌——与治疗反应相关的基因组特征

2025-10-300
PRE
Experiences of metastatic prostate cancer patients with a mainstream genetic testing pathway

转移性前列腺癌患者在使用主流基因检测路径中的体验

2025-10-130
OAAI
The benefits of PCNL combined with ureterorenoscopy compared to isolated PCNL in urolithiasis (PRECISE): a multicentre randomised controlled trial protocol

PCNL联合输尿管肾镜检查相较于孤立性PCNL在尿石症中的益处(PRECISE):一项多中心随机对照试验方案

2025-09-250
OAAI
Prevalence of germline pathogenic variants in 779 patients with metastatic prostate cancer

转移性前列腺癌患者中胚系致病性变异的流行率

2025-09-020
OAAI
How Does Routine Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Modify the Current Management of Prostate Cancer? A Multidisciplinary View

常规前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描如何改变当前的前列腺癌管理模式?——多学科视角

2025-05-010
PRE
Efficacy and Budget Impact of a Tailored Psychological Intervention Program Targeting Cancer Patients With Adjustment Disorder: A Randomised Controlled Trial

针对伴有适应障碍的癌症患者的个性化心理干预方案的疗效与预算影响:一项随机对照试验

2025-03-010
OAAI